Test ID: MAPTK
MAPT Gene, Sequence Analysis, Known Mutation
Secondary ID 
A test code used for billing and in test definitions created prior to November 2011
87925
NY State Approved Indicates the status of NY State approval and if the test is orderable for NY State clients.
Conditional
Useful For Suggests clinical disorders or settings where the test may be helpful
Screening of at-risk individuals when a mutation in the MAPT gene has been identified in an affected family member
Genetics Test Information Provides information that may help with selection of the correct test or proper submission of the test request
Documentation of the specific familial mutation must be provided with the specimen in order to perform this test.
Special Instructions and Forms Describes specimen collection and preparation information, test algorithms, and other information pertinent to test. Also includes pertinent information and consent forms to be used when requesting a particular test
Method Name A short description of the method used to perform the test
Polymerase Chain Reaction (PCR)/DNA Sequencing Analysis
(PCR is utilized pursuant to a license agreement with Roche Molecular Systems, Inc.)
Reporting Name A shorter/abbreviated version of the Published Name for a test; an abbreviated test name
MAPT Known Mutation
Aliases Lists additional common names for a test, as an aid in searching
Frontotemporal dementia
Microtubule-associated protein tau
Pick's disease
Tau
Tauopathy
Microtubule-associated protein tau
Pick's disease
Tau
Tauopathy
External
link
PDF
document
Excel
document
Word
document